Costa Carlos has filed 18 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 230000 shares of Foghorn Therapeutics Inc. ($FHTX) on January 30, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | A | Stock option (right to buy) | 230000 | $5.71 | 230,000.0000 | 63,029,293 | 9999.99% | 0.36% |
| Jan. 22, 2025 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | A | Stock Option (right to buy) | 115000 | $4.37 | 115,000.0000 | 54,899,432 | 9999.99% | 0.21% |
| Sept. 20, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | S | Common Stock | 35756 | $10.04 | 0.0000 | 41,974,484 | 100.00% | 0.09% |
| Sept. 23, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Common Stock | 857 | $3.72 | 857.0000 | 41,974,484 | 9999.99% | 0.00% |
| Sept. 23, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | S | Common Stock | 857 | $10.17 | 0.0000 | 41,974,484 | 100.00% | 0.00% |
| Sept. 20, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Stock Option (right to buy) | 35756 | $0.00 | 40,646.0000 | 41,974,484 | 46.80% | 0.09% |
| Sept. 23, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Stock Option (right to buy) | 857 | $0.00 | 39,789.0000 | 41,974,484 | 2.11% | 0.00% |
| Sept. 20, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Common Stock | 35756 | $3.72 | 35,756.0000 | 41,974,484 | 9999.99% | 0.09% |
| Sept. 18, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | S | Common Stock | 11574 | $10.05 | 0.0000 | 41,974,484 | 100.00% | 0.03% |
| Sept. 18, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Stock Option (right to buy) | 11574 | $0.00 | 76,402.0000 | 41,974,484 | 13.16% | 0.03% |
| Sept. 18, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Common Stock | 11574 | $3.72 | 11,574.0000 | 41,974,484 | 9999.99% | 0.03% |
| Sept. 16, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Stock Option (right to buy) | 400 | $0.00 | 98,248.0000 | 41,974,484 | 0.41% | 0.00% |
| Sept. 17, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Common Stock | 10272 | $3.72 | 10,272.0000 | 41,974,484 | 9999.99% | 0.02% |
| Sept. 17, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | S | Common Stock | 10272 | $10.04 | 0.0000 | 41,974,484 | 100.00% | 0.02% |
| Sept. 16, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | S | Common Stock | 400 | $10.00 | 0.0000 | 41,974,484 | 100.00% | 0.00% |
| Sept. 17, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Stock Option (right to buy) | 10272 | $0.00 | 87,976.0000 | 41,974,484 | 10.46% | 0.02% |
| Sept. 16, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | M | Common Stock | 400 | $3.72 | 400.0000 | 41,974,484 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Foghorn Therapeutics Inc. | $FHTX | Costa Carlos | Chief People Officer | A | Stock Option (right to buy) | 90000 | $3.06 | 90,000.0000 | 41,974,484 | 9999.99% | 0.21% |